Analysts have slightly lowered their price target for Marex Group from $49.33 to $47.67. This change reflects recent updates to the company’s growth and profitability outlook.
What's in the News
- NINGI Research announced a short position in Marex Group, alleging a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to conceal losses and inflate profits (Periodical).
- A securities class action lawsuit has been filed against Marex Group and certain executives. Plaintiffs allege misleading statements regarding the company’s business and financials, particularly artificially inflated cash flow and revenues through off-book transactions (Key Development).
- Marex Group issued financial guidance for Q3 2025, projecting revenue of $475 to $485 million and profit after tax between $70 million and $73 million (Key Development).
Valuation Changes
- Consensus analyst price target decreased slightly from $49.33 to $47.67.
- Discount rate remains unchanged at 13.28%.
- Revenue growth outlook has improved modestly, with the projected decline lessening from -7.71% to -7.36%.
- Net profit margin is expected to rise from 17.86% to 18.32%.
- Future P/E ratio is projected to fall from 14.89x to 13.86x.
Have other thoughts on Marex Group?
Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.
Create NarrativeDisclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.